InvestorsHub Logo
Followers 0
Posts 31
Boards Moderated 0
Alias Born 04/24/2012

Re: None

Tuesday, 09/08/2015 6:30:41 PM

Tuesday, September 08, 2015 6:30:41 PM

Post# of 23979
Why does a SVP of a $380M Bio-Tech (trading as high $20) move to a $7.5M Bio-Tech? InMed Appoints Paul Brennan as President & Chief Executive Officer: from NASDAQ:ABUS to OTCQB:IMLFF Sym:IMLFF hmmmm...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.